Prediction of Lymphopenia and Survival with Baseline Absolute Lymphocyte Count and Irradiated Dose to Immune Cells in Patients with Non-Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy

被引：0
|
作者：
Yang, G. [1 ]
Yoon, H. I. [2 ]
Lee, J. G. [1 ]
Kim, J. [1 ,3 ]
Kim, J. [1 ,3 ]
Kim, K. H. [1 ]
机构：
[1] Yonsei Univ, Heavy Ion Therapy Res Inst, Dept Radiat Oncol, Yonsei Canc Ctr,Coll Med, Seoul, South Korea
[2] Yonsei Univ, Dept Radiat Oncol, Yonsei Canc Ctr, Coll Med, Seoul, South Korea
[3] Yonsei Univ, Dept Radiat Oncol, Coll Med, Seoul, South Korea
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2170
引用
收藏
页码：E77 / E78
页数：2
相关论文
共 50 条
  • [31] PET for Prognostic Assessment in Patients with Unresectable Stage III Non-Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
    Yilmaz, Ufuk
    Asuk, Zehra
    Koparal, Hakan
    Ozbilek, Engin
    Korkmaz, Esra
    Yalcin, Burcu
    Yilmaz, Hasan
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S690 - S690
  • [32] Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer
    Abacioglu, U
    Yumuk, PF
    Caglar, H
    Sengoz, M
    Turhal, NS
    BMC CANCER, 2005, 5 (1)
  • [33] Is Human Kallikrein 11 in Non-small Cell Lung Cancer Treated Chemoradiotherapy Associated with Survival?
    Unal, Dilek
    Eroglu, Celalettin
    Tasdemir, Arzu
    Karaman, Hatice
    Kurtul, Neslihan
    Oguz, Arzu
    Goksu, Sema Sezgin
    Kaplan, Bunyamin
    CANCER RESEARCH AND TREATMENT, 2016, 48 (01): : 98 - 105
  • [34] Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer
    Ufuk Abacioglu
    Perran F Yumuk
    Hale Caglar
    Meric Sengoz
    Nazim S Turhal
    BMC Cancer, 5
  • [35] Impact of heart and lung dose on early survival in patients with non-small cell lung cancer treated with chemoradiation
    Tucker, Susan L.
    Liu, Anwen
    Gomez, Daniel
    Tang, Ling Long
    Allen, Pamela
    Yang, Jinzhong
    Liao, Zhongxing
    Grosshans, David
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 (03) : 495 - 500
  • [36] Outcomes of Concurrent Chemoradiotherapy in Elderly Patients with Stage III Non-Small Cell Lung Cancer
    Lee, Seok Ho
    Lee, Seung Heon
    Heo, Ho-Jin
    Sung, Kihoon
    Lee, Kyu Chan
    Jung, Sung Hwan
    Park, Jeong Woong
    Cho, Eun Kyung
    Ahn, Hee Kyung
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S685 - S685
  • [37] Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer
    Vokes, EE
    Crawford, J
    Bogart, J
    Socinski, MA
    Clamon, G
    Green, MR
    CLINICAL CANCER RESEARCH, 2005, 11 (13) : 5045S - 5050S
  • [38] Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy
    Caliman, Enrico
    Fancelli, Sara
    Ottanelli, Carlotta
    Mazzoni, Francesca
    Paglialunga, Luca
    Lavacchi, Daniele
    Michelet, Marta Rita Gatta
    Giommoni, Elisa
    Napolitano, Brunella
    Scolari, Federico
    Voltolini, Luca
    Comin, Camilla Eva
    Pillozzi, Serena
    Antonuzzo, Lorenzo
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2022, 32
  • [39] Radical concurrent chemoradiotherapy (CRT) for non-small cell lung cancer (NSCLC)
    Stilwell, C. H.
    Shrimali, R. K.
    Sharma, R. N.
    Nicolson, M. C.
    Steven, E.
    Bissett, J. D.
    LUNG CANCER, 2013, 79 : S62 - S63
  • [40] Oesophageal Toxicity and Hypofractionated Concurrent Chemoradiotherapy for Non-small Cell Lung Cancer
    Tho, L. M.
    Mahmood, R.
    Leitch, M.
    Brisbane, I.
    Kakumanu, S.
    Mohammed, N.
    CLINICAL ONCOLOGY, 2009, 21 (01) : 74 - 74
12345